Should we be reassured about sitagliptin?

Jodi Segal

School of Medicine

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Article number	f3051
Journal	BMJ (Online)
Volume	346
Issue number	7908
DOIs	https://doi.org/10.1136/bmj.f3051
State	Published - May 18 2013

ASJC Scopus subject areas

General Medicine

Access to Document

10.1136/bmj.f3051

Other files and links

Cite this

@article{6280d2f7ccd94d19b09f4d1e25b137ca,

title = "Should we be reassured about sitagliptin?",

author = "Jodi Segal",

year = "2013",

month = may,

day = "18",

doi = "10.1136/bmj.f3051",

language = "English (US)",

volume = "346",

journal = "BMJ (Online)",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

number = "7908",

}

TY - JOUR

T1 - Should we be reassured about sitagliptin?

AU - Segal, Jodi

PY - 2013/5/18

Y1 - 2013/5/18

UR - https://www.scopus.com/pages/publications/84878333710

UR - https://www.scopus.com/pages/publications/84878333710#tab=citedBy

U2 - 10.1136/bmj.f3051

DO - 10.1136/bmj.f3051

M3 - Editorial

C2 - 23674336

AN - SCOPUS:84878333710

SN - 0959-8146

VL - 346

JO - BMJ (Online)

JF - BMJ (Online)

IS - 7908

M1 - f3051

ER -